ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4,701 | 45.52197 | 0 |
male
| 0 | 7 | 872 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 5 |
$11-$25k
| 9 | 40,904 | 23,198.3906 | 26,326 | 14.5 |
white
| 22.5 | 12 | 0.843994 | 0.790894 | 3 | 0 | 0 |
no
| 0.8 | 0.75 |
no dnr
| 7 | 101 | 7.099609 | 104 | 28 | 36.69531 | null | 2.5 | 0.699951 | 0.699951 | 138 | null | 125 | 21 | null | 0 | 0 |
no(M2 and SIP pres)
| 0 |
4,702 | 67.69897 | 1 |
male
| 0 | 6 | 537 |
COPD
|
COPD/CHF/Cirrhosis
| 3 | 10 |
under $11k
| 0 | 13,530 | 8,061.7969 | 8,794 | 27 |
white
| 18.796875 | 31 | 0.86499 | 0.776978 | 1 | 1 | 0 |
no
| 0.7 | 0.6 |
no dnr
| 6 | 103 | 2.799805 | 65 | 24 | 38.19531 | 310 | 2.199707 | null | 0.799927 | 137 | 7.439453 | 126 | 8 | 2,895 | null | 2 |
no(M2 and SIP pres)
| 2 |
4,703 | 72.93597 | 1 |
male
| 1 | 4 | 4 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 7 |
under $11k
| 0 | 91,573 | 50,005.9688 | 52,111 | 73 |
white
| 58 | 95 | 0.007 | 0.001 | 6 | 0 | 0 |
no
| null | null |
no dnr
| 4 | 58 | 10.898438 | 60 | 10 | 38.09375 | 136.65625 | null | null | 0.599976 | 129 | 7.389648 | 112 | 26 | 670 | null | 1 |
<2 mo. follow-up
| 1 |
4,704 | 67.01398 | 1 |
female
| 0 | 17 | 414 |
MOSF w/Malig
|
ARF/MOSF
| 1 | 10 |
under $11k
| 0 | 49,608 | 30,856.4219 | 29,589 | 15.666664 |
white
| 29.699219 | 24 | 0.368958 | 0.250977 | 13 | 0 | 0 |
metastatic
| 0.2 | 0.2 |
dnr after sadm
| 2 | 118 | 13 | 65 | 42 | 37.89844 | 253.3125 | 2.599609 | 1.699951 | 0.5 | 142 | 7.439453 | 91 | 13 | 6,340 | 1 | 0 |
adl>=4 (>=5 if sur)
| 0 |
4,705 | 44.64297 | 1 |
female
| 0 | 44 | 842 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 |
under $11k
| 0 | 127,319 | null | null | 32.25 |
other
| 23.796875 | 32 | 0.85791 | 0.80896 | 2 | 0 | 0 |
no
| null | null |
no dnr
| 44 | 53 | 5.299805 | 70 | 24 | 35.09375 | 357.125 | null | 2.299805 | 1.799805 | 131 | 7.489258 | 82 | 54 | 940 | null | null |
no(M2 and SIP pres)
| 1.867188 |
4,706 | 80.46295 | 0 |
female
| 0 | 96 | 868 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 17 | null | 41 | null | 143,812.875 | 139,211 | 36.25 |
white
| 29.398438 | 36 | 0.373962 | 0.255981 | 5 | 0 | 0 |
no
| 0.3 | 0.1 |
no dnr
| 96 | 155 | 9.599609 | 125 | 36 | 36.39844 | 142.84375 | null | null | 1.399902 | 128 | 7.509766 | 1.399902 | 26 | 3,270 | null | 0 |
SIP>=30
| 0 |
4,707 | 72.16998 | 1 |
female
| 0 | 10 | 42 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | 16 |
under $11k
| 0 | 10,077 | 6,900.418 | 7,553 | 10 |
white
| 18.699219 | 18 | 0.807983 | 0.689941 | 1 | 0 | 0 |
yes
| 0.5 | 0.5 |
dnr before sadm
| -1 | 85 | 5.799805 | 105 | 24 | 35.39844 | null | null | 0.799927 | 1 | 143 | null | 77 | 13 | 3,425 | 0 | 1 |
<2 mo. follow-up
| 1 |
4,708 | 60.668 | 1 |
male
| 0 | 6 | 40 |
Lung Cancer
|
Cancer
| 1 | 12 |
$11-$25k
| 0 | 15,007 | 7,510.8633 | 3,060 | 15 |
white
| 16.597656 | 7 | 0.725952 | 0.452942 | 1 | 0 | 0 |
metastatic
| null | null |
no dnr
| 6 | 133 | 10.398438 | 135 | 26 | 35.59375 | 270 | null | 0.5 | 1.099854 | 139 | 7.439453 | 247 | 21 | 3,745 | 0 | null |
<2 mo. follow-up
| 0.494751 |
4,709 | 76.41595 | 1 |
female
| 0 | 7 | 141 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | null | null | 0 | 13,907 | 8,406.4141 | 8,812 | 14 |
black
| 24.796875 | 48 | 0.75293 | 0.674927 | 1 | 1 | 0 |
no
| 0.6 | 0.55 |
no dnr
| 7 | 115 | 0.799927 | 70 | 32 | 38.19531 | 288 | 1.799805 | 0.699951 | 2.099609 | 132 | 7.359375 | 106 | 77 | 1,445 | null | null | null | 3.365723 |
4,710 | 56.57199 | 0 |
female
| 0 | 11 | 867 |
Lung Cancer
|
Cancer
| 1 | 13 | null | 0 | 11,383 | 7,596.5508 | 7,687 | 11 |
white
| 25.097656 | 17 | 0.541992 | 0.218994 | 1 | 0 | 0 |
metastatic
| 0.7 | 0.4 |
no dnr
| 11 | 120 | 6.099609 | 125 | 30 | 35.79688 | 263.3125 | 1.199951 | 3.799805 | 1.099854 | 137 | 7.389648 | 69 | 26 | 3,500 | 1 | 1 |
no(M2 and SIP pres)
| 1 |
4,711 | 28.786 | 0 |
female
| 0 | 10 | 867 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 16 |
>$50k
| 0 | 31,965 | 20,141.1094 | 20,082 | 14 |
black
| 27.398438 | 46 | 0.869995 | 0.823975 | 1 | 0 | 0 |
no
| 0.7 | 0.7 |
no dnr
| 10 | 65 | 1.299805 | 140 | 13 | 38.5 | 167.5 | 2.5 | 4.599609 | 1.899902 | 143 | 7.349609 | 53 | 39 | 1,475 | 1 | 1 |
no(M2 and SIP pres)
| 1 |
4,712 | 75.39197 | 1 |
female
| 0 | 8 | 11 |
Lung Cancer
|
Cancer
| 1 | 12 |
$25-$50k
| 0 | 7,706 | 5,489.1211 | 5,390 | 6.5 |
white
| 23 | 13 | 0.537964 | 0.214996 | 1 | 0 | 0 |
metastatic
| 0.5 | 0.3 |
dnr after sadm
| 2 | 60 | 20.296875 | 115 | 28 | 36.29688 | 156.65625 | 2.5 | 0.399963 | 0.5 | 137 | 7.489258 | 99 | 14 | 1,275 | null | 0 |
<2 mo. follow-up
| 0 |
4,713 | 54.18799 | 0 |
male
| 0 | 20 | 866 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 12 |
$25-$50k
| 0 | 51,179 | 32,586.8594 | 33,527 | 21 |
white
| 26.296875 | 43 | 0.822998 | 0.711914 | 1 | 1 | 0 |
no
| 0.6 | 0.55 |
no dnr
| 20 | 153 | 13.099609 | 145 | 12 | 37.69531 | 187.5 | null | null | 1.199951 | 138 | 7.479492 | 141 | 23 | 3,055 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
4,714 | 72.68195 | 1 |
male
| 1 | 20 | 20 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 8 |
$11-$25k
| 9 | 96,468 | 54,964.375 | 56,554 | 37 |
white
| 20.296875 | 29 | 0.797974 | 0.731934 | 2 | 0 | 0 |
no
| 0.2 | 0.15 |
dnr after sadm
| 5 | 67 | 16.296875 | 115 | 37 | 36.29688 | 300 | 2.899902 | 1.599854 | 0.899902 | 136 | 7.319336 | 95 | 18 | 1,110 | null | 0 |
<2 mo. follow-up
| 0 |
4,715 | 69.14398 | 1 |
female
| 1 | 48 | 48 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 | null | 0 | 81,683 | 50,131.6562 | 49,244 | 26.25 |
white
| 38.09375 | 56 | 0.420959 | 0.300964 | 4 | 0 | 0 |
no
| 0.6 | 0.4 |
dnr after sadm
| 31 | 159 | 12 | 125 | 8 | 38 | 152.5 | 3.399902 | 0.399963 | 5 | 145 | 7.639648 | 198 | 102 | 5,040 | null | 4 |
<2 mo. follow-up
| 4 |
4,716 | 25.51399 | 1 |
female
| 1 | 24 | 24 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 13 |
>$50k
| 0 | 214,081 | null | null | 43.666657 |
white
| 24.796875 | 34 | 0.85791 | 0.80896 | 31 | 0 | 0 |
no
| null | null |
dnr after sadm
| 22 | 120 | 3.199707 | 125 | 10 | 36 | 236 | 2.5 | 3.299805 | 0.799927 | 140 | 7.329102 | 121 | 13 | 1,165 | null | 1 |
<2 mo. follow-up
| 1 |
4,717 | 63.16199 | 1 |
female
| 0 | 31 | 49 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 | null | 9 | 46,093 | 30,062.0469 | 32,577 | 23.75 |
white
| 28.699219 | 44 | 0.645996 | 0.545898 | 1 | 0 | 0 |
yes
| null | null |
no dnr
| 31 | 93 | 15.5 | 100 | 22 | 36.59375 | 292 | null | 0.399963 | 0.799927 | 140 | 7.399414 | 130 | 21 | 2,200 | null | null |
<2 mo. follow-up
| 2.745606 |
4,718 | 76.474 | 0 |
male
| 0 | 10 | 865 |
Colon Cancer
|
Cancer
| 1 | 16 |
>$50k
| 0 | 30,924 | 17,635.5938 | 13,814 | 14 |
white
| 17.796875 | 17 | 0.781982 | 0.543945 | 1 | 0 | 0 |
metastatic
| 1 | 1 |
no dnr
| 10 | 113 | 12.898438 | 75 | 29 | 34.5 | 270 | 2.199707 | null | 2.599609 | 137 | 7.349609 | 49 | 30 | 1,145 | 0 | 5 |
no(M2 and SIP pres)
| 5 |
4,719 | 55.35898 | 1 |
female
| 1 | 18 | 18 |
Lung Cancer
|
Cancer
| 2 | 11 |
$11-$25k
| 9 | 20,520 | 13,153.9531 | 12,673 | 15.666664 |
black
| 38.195313 | 28 | 0.135986 | 0.007 | 1 | 1 | 0 |
metastatic
| null | null |
no dnr
| 18 | 85 | 6.099609 | 68 | 14 | 37.69531 | null | 3.699707 | 0.399963 | 1.399902 | 144 | null | 128 | 16 | null | null | null |
<2 mo. follow-up
| 3.756348 |
4,720 | 65.23499 | 0 |
female
| 0 | 7 | 864 |
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3 | 8 |
under $11k
| 0 | 5,937 | 4,279.6328 | 4,729 | 5.5 |
white
| 15.798828 | 22 | 0.821899 | 0.710938 | 1 | 0 | 0 |
no
| 0.8 | 0.6 |
no dnr
| 7 | 108 | 12 | 130 | 8 | 35.59375 | 312 | 3.899902 | 0.799927 | 2.899902 | 136 | 7.40918 | 687 | 43 | 1,680 | 0 | 0 | null | 0 |
4,721 | 45.142 | 0 |
female
| 0 | 12 | 864 |
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2 | 7 |
under $11k
| 0 | 12,627 | 8,946.6797 | 10,156 | 10.5 |
other
| 16.398438 | 31 | 0.893921 | 0.822998 | 1 | 0 | 0 |
no
| 0.9 | 0.6 |
no dnr
| 12 | 165 | 22.597656 | 120 | 27 | 38.59375 | 56 | 2.099609 | 2.199707 | 1.799805 | 142 | 7.349609 | 183 | 28 | 855 | 6 | 3 |
no(M2 and SIP pres)
| 3 |
4,722 | 63.56497 | 1 |
male
| 0 | 6 | 55 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 6 |
under $11k
| 0 | 3,223 | 2,557.2129 | 2,828 | 8 |
white
| 24.097656 | 50 | 0.817993 | 0.703979 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 6 | 63 | 10.099609 | 131 | 20 | 38.19531 | 308 | 3.199707 | null | 0.699951 | 138 | 7.459961 | 169 | 8 | 1,100 | 0 | 0 |
<2 mo. follow-up
| 0 |
4,723 | 21.489 | 0 |
female
| 0 | 6 | 863 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 2 | null | 0 | 9,570 | 6,218.1367 | 6,122 | 15 |
black
| 18.796875 | 23 | 0.940918 | 0.919922 | 1 | 1 | 0 |
no
| 1 | 1 |
no dnr
| 6 | 105 | 11.398438 | 115 | 24 | 38.09375 | 134.6875 | null | null | 1 | 136 | 7.439453 | 131 | 23 | 2,720 | 0 | null |
no(M2 and SIP pres)
| 0.494751 |
4,724 | 68 | 1 |
female
| 0 | 5 | 29 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | 11 | null | 0 | 12,333 | null | null | 22 |
white
| 19.898438 | 24 | 0.814941 | 0.700928 | 1 | 0 | 0 |
yes
| null | null |
no dnr
| 5 | 108 | 11.5 | 105 | 22 | 36.69531 | 260 | null | null | 0.599976 | 137 | 7.459961 | 136 | 11 | 2,705 | 2 | null |
<2 mo. follow-up
| 1.838867 |
4,725 | 65.23798 | 1 |
male
| 0 | 12 | 574 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | null | null | 0 | 29,142 | 18,768.1875 | 18,177 | 26.5 |
white
| 28 | 58 | 0.684937 | 0.591919 | 1 | 0 | 0 |
yes
| 0.6 | 0.4 |
no dnr
| 12 | 33 | 11.199219 | 150 | 36 | 39.59375 | 157.5 | 2.399902 | 2.599609 | 3.899902 | 135 | 7.369141 | 38 | 55 | 80 | null | 0 |
no(M2 and SIP pres)
| 0 |
4,726 | 81.05695 | 0 |
male
| 0 | 72 | 861 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 18 | null | 0 | null | null | null | 28.25 |
white
| 31.296875 | 68 | 0.524902 | 0.408997 | 5 | 1 | 0 |
no
| 0.7 | 0.5 |
no dnr
| 72 | 65 | 34.796875 | 65 | 22 | 36.09375 | 217.5 | 1.799805 | 37.59375 | 4.199219 | 128 | 7.359375 | 97 | 49 | 5,465 | null | null | null | 3.155762 |
4,727 | 49.18298 | 1 |
male
| 0 | 18 | 41 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4 | 8 |
$11-$25k
| 0 | 28,282 | 18,109.2656 | 17,542 | 18.666656 |
white
| 28.796875 | 52 | 0.792969 | 0.724976 | 1 | 1 | 0 |
no
| 0.85 | 0.75 |
dnr after sadm
| 4 | 73 | 6.899414 | 95 | 26 | 35.69531 | 528 | null | 0.799927 | 1.899902 | 140 | 7.459961 | 109 | 62 | 1,405 | 0 | 0 |
<2 mo. follow-up
| 0 |
4,728 | 83.77496 | 0 |
male
| 0 | 7 | 860 |
COPD
|
COPD/CHF/Cirrhosis
| 1 | 7 |
under $11k
| 0 | 12,501 | 8,251.3281 | 8,286 | 11.5 |
black
| 22.199219 | 41 | 0.715942 | 0.557983 | 1 | 0 | 0 |
no
| 0.7 | 0.6 |
no dnr
| 7 | 45 | 14.798828 | 105 | 27 | 38.89844 | 182.5 | null | 1.5 | 5.899414 | 129 | 7.339844 | 95 | 82 | 115 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
4,729 | 63.95297 | 1 |
female
| 1 | 8 | 8 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 | null | 41 | 96,337 | 52,540.7188 | 47,087 | 36.5 |
white
| 27.097656 | 42 | 0.520996 | 0.404968 | 11 | 0 | 0 |
no
| 0.5 | 0.25 |
dnr after sadm
| 3 | 97 | 8.699219 | 76 | 10 | 35.59375 | null | 3.899902 | 1.199951 | 1.199951 | 139 | null | 82 | 4 | null | null | null |
<2 mo. follow-up
| 2.49707 |
4,730 | 69.86395 | 1 |
male
| 0 | 3 | 15 |
COPD
|
COPD/CHF/Cirrhosis
| 3 | 16 |
under $11k
| 0 | 2,876 | 1,988.1016 | 1,959 | 1 |
black
| 11.798828 | 16 | 0.914917 | 0.856934 | 1 | 0 | 0 |
no
| 0.9 | 0.65 |
no dnr
| 3 | 140 | 7.099609 | 125 | 10 | 37.79688 | 313.3125 | 2.299805 | null | 0.599976 | 129 | 7.469727 | 128 | 5 | 6,280 | 0 | 0 |
<2 mo. follow-up
| 0 |
4,731 | 52.24899 | 1 |
female
| 0 | 8 | 110 |
Lung Cancer
|
Cancer
| 2 | 15 |
>$50k
| 0 | 6,711 | 4,352.8633 | 4,250 | 5 |
white
| 15.699219 | 13 | 0.760986 | 0.507935 | 1 | 0 | 0 |
metastatic
| 0.6 | 0.5 |
no dnr
| 8 | 161 | 9.798828 | 50 | 14 | 38.69531 | 366.625 | null | null | 1.5 | 152 | 7.419922 | 144 | 12 | 2,780 | 2 | 1 |
no(M2 and SIP pres)
| 1 |
4,732 | 52.59399 | 1 |
male
| 0 | 21 | 276 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 10 |
$25-$50k
| 0 | 56,633 | 34,006.4062 | 32,846 | 26.333328 |
white
| 23.097656 | 25 | 0.85498 | 0.804932 | 1 | 0 | 0 |
no
| 0.6 | 0.4 |
no dnr
| 21 | 73 | 15.599609 | 105 | 24 | 37.89844 | 226.90625 | null | 1.099854 | 0.599976 | 133 | 7.40918 | 122 | 7 | null | null | 6 |
adl>=4 (>=5 if sur)
| 6 |
4,733 | 76.72296 | 1 |
female
| 1 | 15 | 15 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 9 | null | 0 | 116,654 | 67,757.1875 | 59,338 | 36 |
white
| 44.195313 | 80 | 0.13797 | 0.063995 | 24 | 0 | 0 |
no
| 0.2 | 0.1 |
dnr after sadm
| 5 | 62 | 6.099609 | 105 | 24 | 37 | 140 | null | 1.099854 | 1.199951 | 142 | 7.519531 | 367 | 41 | 6,315 | null | 3 |
<2 mo. follow-up
| 3 |
4,734 | 78.09698 | 1 |
female
| 1 | 12 | 12 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 8 |
under $11k
| 0 | 63,577 | null | null | 53 |
white
| 43.296875 | 77 | 0.266968 | 0.16098 | 1 | 1 | 0 |
no
| null | null |
dnr after sadm
| 8 | 100 | 7.599609 | 64 | 24 | 39.29688 | null | 3.899902 | 1.399902 | 0.899902 | 141 | null | 92 | 6 | null | null | 6 |
<2 mo. follow-up
| 6 |
4,735 | 76.698 | 1 |
male
| 1 | 5 | 5 |
Coma
|
Coma
| 1 | 16 |
$25-$50k
| 61 | 3,462 | 2,690.6816 | 2,795 | 8 |
white
| 16.398438 | 20 | 0.507935 | 0.435974 | 1 | 0 | 0 |
no
| null | null |
dnr after sadm
| 1 | 113 | 9.398438 | 125 | 10 | 37.79688 | 346.625 | 3.399902 | 2.099609 | 1 | 142 | 7.449219 | 190 | 13 | 2,990 | null | null |
<2 mo. follow-up
| 2.037598 |
4,736 | 64.96399 | 1 |
male
| 1 | 5 | 5 |
MOSF w/Malig
|
ARF/MOSF
| 2 | 12 |
$11-$25k
| 0 | 42,713 | 24,700.4375 | 22,499 | 45 |
white
| 48.398438 | 112 | 0.011 | 0.002 | 12 | 1 | 0 |
metastatic
| null | null |
dnr after sadm
| 3 | 113 | 13.898438 | 115 | 26 | 39.19531 | 96.65625 | null | 1.599854 | 1 | 142 | 7.399414 | 114 | 18 | 3,270 | null | null |
<2 mo. follow-up
| 2.539551 |
4,737 | 53.63397 | 1 |
female
| 0 | 50 | 156 |
MOSF w/Malig
|
ARF/MOSF
| 1 | 14 |
$11-$25k
| 0 | 204,110 | 114,735.125 | 101,973 | 33.25 |
white
| 33.09375 | 54 | 0.291992 | 0.181976 | 13 | 0 | 0 |
metastatic
| 0.7 | 0.5 |
dnr after sadm
| 24 | 58 | 3.399902 | 105 | 10 | 35.5 | 380 | null | 3.799805 | 0.899902 | 130 | 7.489258 | 97 | 15 | 1,050 | null | 0 |
adl>=4 (>=5 if sur)
| 0 |
4,738 | 72.33099 | 0 |
female
| 0 | 19 | 854 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 5 |
under $11k
| 0 | 34,368 | 20,941.1094 | 20,411 | 16.666656 |
black
| 22.5 | 31 | 0.803955 | 0.738892 | 1 | 1 | 0 |
no
| 0.7 | 0.9 |
no dnr
| 19 | 77 | 5.699219 | 65 | 20 | 36.29688 | null | null | 0.599976 | 1.099854 | 142 | null | 114 | 12 | 3,900 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
4,739 | 45.38498 | 1 |
female
| 1 | 8 | 8 |
MOSF w/Malig
|
ARF/MOSF
| 1 | null | null | 0 | 43,002 | 25,865.5781 | 28,655 | 21 |
black
| 44.796875 | 75 | 0.053993 | 0.017998 | 9 | 0 | 0 |
metastatic
| 0.2 | 0.1 |
dnr after sadm
| 7 | 65 | 12.599609 | 85 | 16 | 36.39844 | null | 3.099609 | 0.699951 | 1.399902 | 137 | null | 97 | 14 | 4,025 | null | null |
<2 mo. follow-up
| 3.200195 |
4,740 | 50.82797 | 1 |
male
| 0 | 6 | 18 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 11 |
under $11k
| 0 | 13,347 | 8,863.7734 | 8,565 | 17 |
black
| 29.097656 | 53 | 0.781982 | 0.710938 | 1 | 0 | 0 |
no
| 0.8 | 0.6 |
no dnr
| 6 | 112 | 18.699219 | 135 | 28 | 36.5 | 175 | 2.299805 | 1.699951 | 2.5 | 133 | 7.299805 | 220 | 56 | 955 | 0 | null |
<2 mo. follow-up
| 0.494751 |
4,741 | 75.02795 | 0 |
male
| 0 | 11 | 853 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | 12 |
$11-$25k
| 0 | 24,806 | 15,019.7969 | 15,288 | 18.5 |
white
| 30.699219 | 34 | 0.611938 | 0.424988 | 1 | 1 | 0 |
no
| null | null |
no dnr
| 11 | 112 | 3.099609 | 145 | 67 | 38.29688 | 106.10938 | 3 | 6.199219 | 1 | 138 | 7.419922 | 135 | 9 | 3,420 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
4,742 | 63.56998 | 0 |
female
| 0 | 14 | 853 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 | null | 0 | 46,649 | 28,247.2812 | 32,706 | 20 |
white
| 28.5 | 50 | 0.740967 | 0.659912 | 1 | 0 | 0 |
no
| 0.7 | 0.6 |
no dnr
| 14 | 77 | 9.199219 | 120 | 26 | 38 | 323.75 | null | 1.899902 | 1.699951 | 136 | 7.509766 | 114 | 24 | 3,850 | null | 0 |
no(M2 and SIP pres)
| 0 |
4,743 | 76.61597 | 0 |
female
| 0 | 4 | 853 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 10 | null | 0 | 6,633 | 4,034.3262 | 3,425 | 7 |
white
| 16.199219 | 19 | 0.86792 | 0.780884 | 1 | 1 | 0 |
no
| 0.8 | 0.6 |
no dnr
| 4 | 112 | 15.898438 | 165 | 46 | 37.69531 | null | 3.699707 | null | 0.899902 | 138 | null | 129 | 23 | 1,110 | 0 | null |
no(M2 and SIP pres)
| 0.494751 |
4,744 | 63.87399 | 1 |
female
| 1 | 8 | 8 |
Coma
|
Coma
| 0 | null | null | 61 | 179,570 | 96,443 | 86,563 | 50.5 |
white
| 33.695313 | 78 | 0.065994 | 0.035995 | 21 | 0 | 0 |
no
| null | null |
dnr after sadm
| 8 | 63 | 5.899414 | 135 | 10 | 35.5 | 220 | 2.099609 | 2.899902 | 2.799805 | 142 | 7.509766 | 374 | 62 | 3,760 | null | null |
<2 mo. follow-up
| 2.06543 |
4,745 | 65.42896 | 1 |
male
| 1 | 11 | 11 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 11 | null | 0 | 43,352 | 25,331.6875 | 24,829 | 35 |
white
| 27.699219 | 30 | 0.668945 | 0.572998 | 2 | 0 | 0 |
yes
| 0.5 | 0.3 |
dnr after sadm
| 9 | 58 | 12.099609 | 110 | 8 | 38.29688 | 340 | null | 0.5 | 2.699707 | 145 | 7.369141 | 299 | 50 | 5,645 | null | 0 |
<2 mo. follow-up
| 0 |
4,746 | 69.008 | 1 |
male
| 1 | 3 | 3 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 11 |
$25-$50k
| 100 | 20,466 | 11,629.3125 | 11,087 | 32 |
white
| 54.796875 | 102 | 0 | 0 | 2 | 0 | 0 |
no
| null | null |
dnr after sadm
| 2 | 62 | 18.097656 | 135 | 41 | 38.89844 | 226.65625 | null | 0.5 | 1 | 132 | 7.569336 | 184 | 17 | 6,840 | null | 0 |
<2 mo. follow-up
| 0 |
4,747 | 77.19397 | 1 |
male
| 1 | 23 | 23 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 9 | null | 26 | 216,528 | 124,308.75 | 116,326 | 36.333313 |
white
| 27.199219 | 42 | 0.477966 | 0.359985 | 33 | 0 | 0 |
no
| null | null |
dnr after sadm
| 23 | 100 | 11.5 | 74 | 20 | 37.59375 | 123.32812 | null | null | 1.899902 | 139 | 7.289062 | 66 | 27 | null | null | 1 |
<2 mo. follow-up
| 1 |
4,748 | 62.88797 | 0 |
male
| 0 | 22 | 847 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 14 | null | 0 | 140,338 | 81,788.9375 | 85,116 | 31 |
black
| 23.597656 | 48 | 0.766968 | 0.692993 | 10 | 0 | 0 |
no
| 0.95 | 0.95 |
no dnr
| 22 | 95 | 12.5 | 110 | 24 | 37.79688 | 169.375 | null | null | 1.199951 | 136 | 7.429688 | 98 | 21 | 2,870 | null | 0 |
SIP>=30
| 0 |
4,749 | 61.12299 | 1 |
female
| 1 | 15 | 15 |
Coma
|
Coma
| 1 | 14 |
$25-$50k
| 94 | 38,083 | 22,628.7812 | 22,674 | 16 |
white
| 25.5 | 27 | 0.187988 | 0.129974 | 3 | 0 | 0 |
no
| 0.1 | 0.1 |
dnr after sadm
| 6 | 125 | 19.296875 | 105 | 26 | 37.19531 | 343.4375 | 3.799805 | 0.699951 | 1.399902 | 137 | 7.419922 | 285 | 36 | 1,093 | null | 1 |
<2 mo. follow-up
| 1 |
4,750 | 43.38098 | 0 |
female
| 0 | 40 | 847 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 16 |
$25-$50k
| 41 | 95,022 | 60,139.0938 | 61,095 | 25.25 |
black
| 37 | 64 | 0.481995 | 0.363953 | 1 | 0 | 0 |
no
| 0.65 | 0.6 |
no dnr
| 40 | 50 | 5 | 145 | 40 | 33.89844 | 55 | 4.699219 | 4.099609 | 2.299805 | 152 | 7.439453 | 393 | 25 | 2,750 | null | 0 |
no(M2 and SIP pres)
| 0 |
4,751 | 61.78497 | 0 |
male
| 0 | 51 | 847 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 15 | null | 100 | 113,757 | 66,821.8125 | 77,115 | 30 |
white
| 28.199219 | 49 | 0.276978 | 0.168976 | 2 | 0 | 0 |
no
| 0.2 | 0.1 |
dnr after sadm
| 12 | 108 | 6.5 | 105 | 26 | 35.69531 | 150 | null | null | 0.5 | 134 | 7.319336 | 80 | 11 | 1,390 | null | 0 |
adl>=4 (>=5 if sur)
| 0 |
4,752 | 70.02295 | 1 |
male
| 1 | 12 | 12 |
MOSF w/Malig
|
ARF/MOSF
| 1 | 12 |
under $11k
| 0 | 146,048 | 87,808.8125 | 88,876 | 43 |
black
| 59.796875 | 104 | 0 | 0 | 34 | 0 | 0 |
yes
| 0.2 | 0.1 |
dnr after sadm
| 5 | 67 | 11.699219 | 105 | 12 | 38.69531 | 326.625 | 2.099609 | 2.299805 | 0.599976 | 130 | 7.469727 | 157 | 17 | 1,890 | null | 0 |
<2 mo. follow-up
| 0 |
4,753 | 66.41199 | 1 |
female
| 1 | 14 | 14 |
MOSF w/Malig
|
ARF/MOSF
| 2 | 7 |
under $11k
| 0 | 29,635 | 18,554.125 | 18,661 | 20.333328 |
white
| 27.597656 | 46 | 0.448975 | 0.329956 | 8 | 0 | 0 |
metastatic
| 0.4 | 0.2 |
no dnr
| 14 | 73 | 11.699219 | 130 | 10 | 37.69531 | 104 | 1.5 | 1.599854 | 0.699951 | 136 | 7.429688 | 125 | 11 | 2,225 | null | 0 |
<2 mo. follow-up
| 0 |
4,754 | 67.737 | 1 |
male
| 1 | 9 | 9 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 12 |
under $11k
| 44 | 77,412 | 43,302.9688 | 46,105 | 45 |
white
| 32.796875 | 93 | 0.372986 | 0.254944 | 3 | 1 | 0 |
no
| 0.3 | 0.2 |
dnr after sadm
| 3 | 118 | 10.398438 | 105 | 24 | 37 | 266.625 | null | 0.599976 | 0.799927 | 134 | 7.399414 | 128 | 9 | 1,150 | null | 0 |
<2 mo. follow-up
| 0 |
4,755 | 46.65598 | 1 |
male
| 0 | 15 | 425 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 16 | null | 0 | 45,527 | 25,871.6406 | 26,413 | 21.666656 |
black
| 42 | 59 | 0.55188 | 0.35498 | 1 | 0 | 0 |
no
| 0.65 | 0.55 |
no dnr
| 15 | 95 | 13.699219 | 85 | 20 | 36 | null | null | 0.699951 | 1.099854 | 138 | null | 104 | 18 | 3,950 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
4,756 | 70.073 | 1 |
female
| 0 | 5 | 72 |
CHF
|
COPD/CHF/Cirrhosis
| 4 | 10 |
$11-$25k
| 0 | 4,990 | 3,376.4356 | 3,987 | 11 |
black
| 19.097656 | 31 | 0.821899 | 0.709961 | 1 | 1 | 0 |
yes
| 0.7 | 0.2 |
no dnr
| 5 | 75 | 12.298828 | 60 | 14 | 36 | 493.3125 | null | null | 6.299805 | 137 | 7.539062 | 108 | 53 | 0 | 5 | 5 | null | 5 |
4,757 | 56.75598 | 1 |
male
| 1 | 6 | 6 |
MOSF w/Malig
|
ARF/MOSF
| 1 | 12 |
$25-$50k
| 9 | 31,855 | 18,527.2031 | 19,456 | 35 |
white
| 49.296875 | 84 | 0.046997 | 0.014999 | 1 | 0 | 0 |
yes
| 0.4 | 0.2 |
dnr after sadm
| 6 | 80 | 8 | 126 | 22 | 36 | 247.59375 | 3.399902 | 0.599976 | 0.599976 | 132 | 7.439453 | 105 | 6 | null | null | 0 |
<2 mo. follow-up
| 0 |
4,758 | 77.17694 | 1 |
male
| 1 | 5 | 5 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | null | null | 9 | 12,136 | 7,305.8594 | 6,994 | 25 |
white
| 22.796875 | 45 | 0.755981 | 0.678955 | 1 | 0 | 0 |
no
| 0.55 | 0.5 |
dnr after sadm
| 4 | 135 | 9.898438 | 125 | 38 | 36.69531 | 398 | 2.899902 | 1.599854 | 2.299805 | 136 | 7.589844 | 77 | 28 | 4,425 | null | null |
<2 mo. follow-up
| 2.39209 |
4,759 | 64.047 | 1 |
female
| 0 | 22 | 716 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 8 |
under $11k
| 0 | 44,905 | 26,915.875 | 27,255 | 21.666656 |
black
| 32.398438 | 52 | 0.658936 | 0.56189 | 1 | 0 | 0 |
no
| 0.6 | 0.5 |
no dnr
| 22 | 110 | 14.199219 | 95 | 24 | 35.79688 | null | null | null | 0.699951 | 130 | null | 85 | 11 | null | null | 0 | null | 0 |
4,760 | 56.18298 | 1 |
female
| 1 | 5 | 5 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 7 |
$25-$50k
| 44 | 59,066 | 33,900.4375 | 29,200 | 40 |
white
| 48.09375 | 90 | 0.039993 | 0.011999 | 11 | 0 | 0 |
no
| 0 | 0 |
dnr after sadm
| 3 | 65 | 16.898438 | 125 | 24 | 36.5 | 376 | null | null | 1.899902 | 132 | 7.439453 | 257 | 31 | 1,425 | null | 1 |
<2 mo. follow-up
| 1 |
4,761 | 65.31696 | 0 |
female
| 0 | 67 | 839 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 14 | null | 37 | null | 105,694.75 | 107,273 | 25.5 |
white
| 31.699219 | 37 | 0.42395 | 0.304993 | 6 | 0 | 0 |
no
| 0.4 | 0.3 |
no dnr
| 67 | 60 | 20.597656 | 125 | 10 | 38.39844 | 276.625 | 2.399902 | null | 0.899902 | 135 | 7.429688 | 179 | 9 | 990 | null | 0 |
no(M2 and SIP pres)
| 0 |
4,762 | 58.198 | 1 |
male
| 1 | 14 | 14 |
Coma
|
Coma
| 2 | 8 |
$11-$25k
| 94 | 35,896 | null | null | 17 |
white
| 19.796875 | 24 | 0.428955 | 0.35498 | 1 | 1 | 0 |
no
| 0.05 | 0.02 |
dnr after sadm
| 2 | 47 | 12.898438 | 65 | 10 | 38 | 370 | 2.699707 | 5.099609 | 3.5 | 128 | 7.399414 | 155 | 63 | 1,300 | null | 0 |
<2 mo. follow-up
| 0 |
4,763 | 56.646 | 1 |
male
| 0 | 15 | 74 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 11 |
$11-$25k
| 0 | 31,154 | 18,346.0625 | 17,082 | 16.666656 |
black
| 35.09375 | 50 | 0.655884 | 0.47998 | 1 | 1 | 0 |
no
| 0.9 | 0.8 |
no dnr
| 15 | 62 | 23.699219 | 130 | 8 | 36.79688 | 252.5 | null | 2.5 | 1.299805 | 149 | 7.399414 | 212 | 51 | 3,885 | 0 | 5 |
adl>=4 (>=5 if sur)
| 5 |
4,764 | 75.94299 | 1 |
female
| 0 | 22 | 152 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | null |
under $11k
| 0 | 16,361 | 12,048.6797 | 12,880 | 8.666664 |
black
| 23.796875 | 42 | 0.771973 | 0.636963 | 1 | 1 | 0 |
no
| 0.8 | 0.6 |
no dnr
| 22 | 65 | 17 | 115 | 32 | 36.89844 | 372 | 29 | 1 | 5.599609 | 145 | 7.329102 | 92 | 127 | 3,205 | 2 | 1 |
no(M2 and SIP pres)
| 1 |
4,765 | 57.84799 | 1 |
male
| 0 | 8 | 638 |
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2 | 10 |
under $11k
| 0 | 32,299 | 20,089.7656 | 20,786 | 19.5 |
white
| 19 | 25 | 0.785889 | 0.655884 | 4 | 0 | 0 |
no
| 0.7 | 0.7 |
no dnr
| 8 | 117 | 21.898438 | 70 | 24 | 38.09375 | null | 3.299805 | 1.099854 | 1.199951 | 135 | null | 149 | 17 | 1,070 | 1 | 0 |
no(M2 and SIP pres)
| 0 |
4,766 | 64.61896 | 1 |
male
| 0 | 15 | 25 |
MOSF w/Malig
|
ARF/MOSF
| 1 | null | null | 0 | 39,790 | 26,220 | 25,733 | 8.333328 |
white
| 24.296875 | 18 | 0.521973 | 0.405945 | 16 | 0 | 0 |
metastatic
| 0 | 0 |
dnr after sadm
| 1 | 69 | 17.898438 | 138 | 22 | 36.5 | null | 2.199707 | 0.699951 | 0.599976 | 144 | null | 203 | 6 | null | null | null |
<2 mo. follow-up
| 2.929199 |
4,767 | 64.04895 | 0 |
male
| 0 | 7 | 837 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 18 |
>$50k
| 0 | 6,522 | 4,604.7148 | 4,295 | 7.5 |
white
| 16.5 | 24 | 0.895996 | 0.825928 | 1 | 1 | 0 |
no
| null | null |
no dnr
| 7 | 71 | 12.099609 | 80 | 24 | 36.59375 | null | 2.399902 | 0.799927 | 0.799927 | 135 | null | 76 | 9 | 1,350 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
4,768 | 53.172 | 1 |
female
| 1 | 6 | 6 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 14 |
$11-$25k
| 0 | 120,668 | 67,220.1875 | 63,222 | 58 |
asian
| 32.796875 | 45 | 0.608887 | 0.50293 | 23 | 1 | 0 |
no
| null | null |
dnr after sadm
| 6 | 66 | 9.298828 | 84 | 24 | 37.59375 | null | 1 | 3 | 0.799927 | 134 | null | 105 | 2 | 2,300 | null | 1 |
<2 mo. follow-up
| 1 |
4,769 | 61.54398 | 1 |
male
| 0 | 11 | 48 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | 3 | null | 0 | 12,650 | 7,735.4883 | 7,142 | 15 |
white
| 19.097656 | 22 | 0.823975 | 0.712891 | 1 | 0 | 0 |
metastatic
| 0.6 | 0.5 |
no dnr
| 11 | 58 | 10.398438 | 70 | 24 | 34.89844 | 633.25 | null | null | 1.5 | 131 | 7.509766 | 238 | 32 | 1,400 | 5 | 0 |
<2 mo. follow-up
| 0 |
4,770 | 49.67297 | 1 |
female
| 0 | 5 | 11 |
Colon Cancer
|
Cancer
| 1 | 10 |
under $11k
| 0 | 5,648 | null | null | 14 |
black
| 45.296875 | 65 | 0.181976 | 0.014999 | 1 | 0 | 0 |
metastatic
| 0.02 | 0.02 |
dnr after sadm
| 1 | 73 | 10.199219 | 100 | 20 | 36.69531 | 401.625 | 3.699707 | 1.099854 | 0.799927 | 146 | 6.919922 | 195 | 5 | 5,230 | null | 0 |
<2 mo. follow-up
| 0 |
4,771 | 42.01498 | 0 |
male
| 0 | 5 | 835 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 13 |
$11-$25k
| 0 | 12,763 | 9,769.4062 | 11,388 | 16 |
white
| 23.199219 | 32 | 0.878906 | 0.835938 | 1 | 0 | 0 |
no
| 0.8 | 0.8 |
no dnr
| 5 | 72 | 12 | 115 | 24 | 36.59375 | 262.9375 | null | null | 0.899902 | 140 | 7.389648 | 157 | 21 | 2,085 | null | null | null | 2.024414 |
4,772 | 67.73999 | 1 |
male
| 0 | 6 | 285 |
Colon Cancer
|
Cancer
| 1 | 12 |
$11-$25k
| 0 | 5,624 | 3,785.209 | 3,887 | 7 |
white
| 4.5 | 12 | 0.927979 | 0.829956 | 1 | 0 | 0 |
metastatic
| 0.8 | 0.6 |
no dnr
| 6 | 62 | 9.398438 | 135 | 31 | 35.69531 | 223.3125 | null | 2.299805 | 1.899902 | 138 | 7.429688 | 69 | 30 | 785 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
4,773 | 69.83398 | 1 |
female
| 0 | 19 | 581 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 10 |
under $11k
| 0 | 65,899 | 38,949.6562 | 40,096 | 32 |
white
| 22.597656 | 32 | 0.810913 | 0.748901 | 1 | 1 | 0 |
no
| 0.5 | 0.5 |
no dnr
| 19 | 118 | 10.699219 | 115 | 32 | 38.39844 | 97.95312 | 2.399902 | 1.099854 | 1.799805 | 134 | 7.449219 | 221 | 47 | 1,880 | null | 1 |
adl>=4 (>=5 if sur)
| 1 |
4,774 | 49.02399 | 1 |
male
| 0 | 6 | 9 |
Cirrhosis
|
COPD/CHF/Cirrhosis
| 4 | 13 | null | 0 | 5,844 | 3,874.1211 | 5,229 | 8 |
black
| 21.597656 | 18 | 0.824951 | 0.714966 | 1 | 0 | 0 |
no
| 0.8 | 0.6 |
no dnr
| 6 | 68 | 18.898438 | 80 | 23 | 35.39844 | 244 | null | null | 2.299805 | 126 | 7.519531 | 326 | 75 | 3,145 | 0 | 0 |
<2 mo. follow-up
| 0 |
4,775 | 45.24298 | 0 |
female
| 0 | 18 | 832 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | null | null | 0 | 67,484 | 39,542.9375 | 41,029 | 18.666656 |
white
| 24 | 40 | 0.832886 | 0.776978 | 6 | 0 | 0 |
no
| 0.9 | 0.7 |
no dnr
| 18 | 87 | 12 | 75 | 30 | 35.69531 | 181.8125 | null | null | 1.399902 | 139 | 7.359375 | 206 | 31 | 700 | null | null | null | 2.758789 |
4,776 | 58.01498 | 1 |
female
| 1 | 32 | 32 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 6 |
under $11k
| 0 | 265,216 | 147,972.25 | 143,792 | 47 |
other
| 30.199219 | 61 | 0.691895 | 0.600952 | 4 | 0 | 0 |
no
| 0.1 | 0.8 |
dnr after sadm
| 31 | 117 | 21.699219 | 120 | 40 | 38 | 165 | null | null | 1.399902 | 143 | 7.40918 | 181 | 64 | 2,085 | null | 6 |
<2 mo. follow-up
| 6 |
4,777 | 58.20898 | 0 |
male
| 0 | 44 | 831 |
CHF
|
COPD/CHF/Cirrhosis
| 1 | 13 | null | 0 | 122,895 | 79,846.6875 | 80,763 | 19 |
white
| 18.296875 | 8 | 0.894897 | 0.823975 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 44 | 89 | 7.599609 | 70 | 16 | 36 | 228.5625 | 4.199219 | 0.699951 | 0.799927 | 143 | 7.369141 | 74 | 10 | null | 0 | 0 |
no(M2 and SIP pres)
| 0 |
4,778 | 78.461 | 0 |
male
| 0 | 9 | 829 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 12 | null | 0 | 25,238 | 14,528.2891 | 13,822 | 22 |
white
| 24.097656 | 48 | 0.755981 | 0.61499 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 9 | 83 | 12.599609 | 100 | 22 | 36.79688 | null | 3.699707 | null | 0.899902 | 136 | null | 108 | 34 | null | 1 | 1 |
no(M2 and SIP pres)
| 1 |
4,779 | 82.98395 | 1 |
male
| 0 | 9 | 283 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 11 |
under $11k
| 0 | 21,437 | 12,664.7109 | 12,816 | 16.5 |
white
| 32.09375 | 52 | 0.5 | 0.382996 | 4 | 0 | 0 |
no
| null | null |
dnr after sadm
| 6 | 112 | 11.398438 | 65 | 35 | 37.69531 | 170 | null | null | 0.599976 | 137 | 7.40918 | 71 | 8 | 1,770 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
4,780 | 85.72998 | 1 |
male
| 0 | 5 | 372 |
COPD
|
COPD/CHF/Cirrhosis
| 5 | 13 |
$25-$50k
| 0 | 4,450 | null | null | 12 |
white
| 19.199219 | 39 | 0.755981 | 0.613892 | 1 | 1 | 0 |
no
| 0.5 | 0.3 |
dnr after sadm
| 2 | 43 | 16.699219 | 145 | 27 | 36.39844 | 175 | 2.199707 | 1.399902 | 4 | 139 | 7.369141 | 57 | 105 | 720 | null | 2 |
no(M2 and SIP pres)
| 2 |
4,781 | 78.44495 | 1 |
female
| 1 | 6 | 6 |
Coma
|
Coma
| 0 | null | null | 100 | 24,018 | 13,985.0547 | 12,876 | 37 |
black
| 26.796875 | 52 | 0.043999 | 0.021999 | 2 | 0 | 0 |
no
| null | null |
dnr after sadm
| 1 | 45 | 15 | 80 | 12 | 36.79688 | 146 | 2.399902 | 6.299805 | 2.899902 | 131 | 7.459961 | 240 | 83 | 727 | null | 6 |
<2 mo. follow-up
| 6 |
4,782 | 74.56799 | 1 |
male
| 0 | 107 | 349 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | null | null | 0 | null | 174,840.875 | 172,957 | 32.75 |
white
| 33.195313 | 84 | 0.579956 | 0.469971 | 1 | 1 | 0 |
no
| null | null |
dnr after sadm
| 65 | 107 | 9.099609 | 84 | 30 | 37.69531 | 518.25 | null | 0.699951 | 1.199951 | 131 | 7.30957 | 223 | 14 | 1,170 | null | null | null | 2.84668 |
4,783 | 74.09198 | 0 |
female
| 0 | 11 | 824 |
Coma
|
Coma
| 0 | 6 |
under $11k
| 55 | 30,836 | 19,206.1094 | 22,714 | 34 |
white
| 21.5 | 25 | 0.417969 | 0.343994 | 1 | 0 | 0 |
no
| 0.5 | 0.5 |
no dnr
| 11 | 58 | 0.399963 | 135 | 31 | 37.89844 | 185 | 2 | 8.5 | 4.5 | 129 | 7.289062 | 63 | 100 | 440 | null | 4 |
adl>=4 (>=5 if sur)
| 4 |
4,784 | 43.13498 | 0 |
female
| 0 | 55 | 824 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 |
under $11k
| 0 | null | 123,479.062 | 130,232 | 30 |
white
| 29.398438 | 71 | 0.730957 | 0.646973 | 29 | 1 | 0 |
no
| null | null |
no dnr
| 55 | 137 | 29.597656 | 145 | 14 | 36.79688 | 140 | null | null | 2.299805 | 150 | 7.449219 | 96 | 46 | 4,115 | null | 3 |
SIP>=30
| 3 |
4,785 | 52.99899 | 1 |
male
| 1 | 5 | 5 |
MOSF w/Malig
|
ARF/MOSF
| 1 | 12 |
>$50k
| 0 | 43,817 | 25,759.375 | 24,727 | 28 |
white
| 35.195313 | 55 | 0.250977 | 0.146973 | 8 | 0 | 0 |
metastatic
| 0.1 | 0 |
dnr after sadm
| 5 | 122 | 17.199219 | 115 | 22 | 38.89844 | 292.5625 | null | null | 1.799805 | 139 | 7.40918 | 251 | 25 | 3,165 | null | 0 |
<2 mo. follow-up
| 0 |
4,786 | 44.383 | 1 |
male
| 0 | 11 | 162 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 12 |
$25-$50k
| 0 | 24,372 | 14,127.7031 | 12,104 | 19.5 |
black
| 21.097656 | 18 | 0.901978 | 0.835938 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 11 | 98 | 1 | 115 | 36 | 35.09375 | 293.3125 | 1.299805 | 11.898438 | 2.699707 | 145 | 7.349609 | 181 | 87 | 915 | 0 | 2 |
no(M2 and SIP pres)
| 2 |
4,787 | 62.771 | 1 |
male
| 0 | 5 | 24 |
Colon Cancer
|
Cancer
| 2 | 18 | null | 0 | 5,826 | 3,842.9121 | 3,791 | 7 |
white
| 43.59375 | 59 | 0.181976 | 0.014999 | 1 | 1 | 0 |
metastatic
| 0.65 | 0.3 |
no dnr
| 5 | 102 | 13.298828 | 95 | 28 | 37.29688 | 128.3125 | null | 0.799927 | 7.399414 | 137 | 7.439453 | 100 | 78 | 15 | 4 | 1 |
<2 mo. follow-up
| 1 |
4,788 | 57.30298 | 0 |
female
| 0 | 6 | 821 |
COPD
|
COPD/CHF/Cirrhosis
| 3 | 12 |
$11-$25k
| 0 | 6,106 | 3,974.8887 | 4,224 | 8 |
white
| 16.097656 | 23 | 0.921997 | 0.86792 | 1 | 0 | 0 |
no
| 0.8 | 0.75 |
no dnr
| 6 | 118 | 18 | 102 | 40 | 35.09375 | 142.5 | null | null | 1.299805 | 135 | 7.399414 | 180 | 29 | 3,060 | null | null |
no(M2 and SIP pres)
| 2.344727 |
4,789 | 69.62396 | 1 |
female
| 1 | 69 | 69 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | null |
$11-$25k
| 0 | null | 225,678.375 | 222,615 | 47 |
white
| 31.796875 | 57 | 0.557983 | 0.444946 | 10 | 0 | 0 |
no
| 0.1 | 0.1 |
dnr after sadm
| 67 | 62 | 11.798828 | 150 | 30 | 36.5 | 157.5 | 1.799805 | null | 0.699951 | 136 | 7.359375 | 95 | 12 | 950 | null | 5 | null | 5 |
4,790 | 33.94897 | 0 |
female
| 0 | 38 | 820 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 9 |
under $11k
| 9 | 70,401 | 43,772.875 | 45,305 | 21.25 |
white
| 25.699219 | 26 | 0.846924 | 0.793945 | 2 | 0 | 0 |
no
| 0.5 | 0.5 |
no dnr
| 38 | 133 | 11.5 | 85 | 28 | 37.59375 | null | null | 0.599976 | 1.399902 | 140 | null | 109 | 18 | null | null | 0 | null | 0 |
4,791 | 80.51495 | 1 |
female
| 1 | 6 | 6 |
Coma
|
Coma
| 1 | 14 | null | 55 | 22,544 | 12,786.2422 | 17,636 | 32 |
white
| 21.199219 | 34 | 0.358948 | 0.28595 | 1 | 0 | 1 |
no
| 0.2 | 0.15 |
dnr after sadm
| 2 | 57 | 34.398438 | 95 | 31 | 37.79688 | 152.5 | null | null | 2.699707 | 130 | 7.419922 | 56 | 75 | 344 | null | 2 |
<2 mo. follow-up
| 2 |
4,792 | 64.61298 | 0 |
male
| 0 | 73 | 819 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 | null | 0 | null | 127,890.562 | 134,806 | 25.5 |
white
| 22.398438 | 18 | 0.80188 | 0.735962 | 4 | 0 | 0 |
no
| 0.8 | 0.75 |
no dnr
| 73 | 85 | 15.398438 | 55 | 40 | 35 | 182.5 | null | null | 0.899902 | 136 | 7.459961 | 106 | 20 | 2,680 | 0 | 0 |
adl>=4 (>=5 if sur)
| 0 |
4,793 | 61.83197 | 0 |
male
| 0 | 12 | 819 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | null | null | 41 | 62,594 | 34,359.5938 | 31,317 | 30.5 |
white
| 19.296875 | 39 | 0.764893 | 0.689941 | 2 | 0 | 0 |
no
| 0.88 | 0.85 |
no dnr
| 12 | 32 | 14.599609 | 35 | 0 | 36.79688 | 140 | null | null | 3.5 | 142 | 7.519531 | 226 | 73 | 0 | null | null | null | 2.108887 |
4,794 | 70.70795 | 0 |
male
| 0 | 12 | 818 |
CHF
|
COPD/CHF/Cirrhosis
| 4 | 12 |
$25-$50k
| 0 | 32,075 | 20,653.9531 | 23,694 | 26 |
white
| 30.699219 | 42 | 0.667969 | 0.494995 | 1 | 1 | 0 |
no
| 0.6 | 0.5 |
no dnr
| 12 | 72 | 20.398438 | 105 | 22 | 37.79688 | 134.6875 | 1.899902 | 1.399902 | 1.899902 | 144 | 7.449219 | 137 | 41 | 2,850 | null | 0 |
no(M2 and SIP pres)
| 0 |
4,795 | 69.03998 | 0 |
male
| 0 | 3 | 817 |
CHF
|
COPD/CHF/Cirrhosis
| 4 | 11 |
$25-$50k
| 0 | 2,368 | 1,803.2598 | 1,889 | 7 |
white
| 14.798828 | 6 | 0.898926 | 0.830933 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 3 | 110 | 16.597656 | 110 | 36 | 39.19531 | 263.3125 | 2.299805 | 3.299805 | 1.199951 | 141 | 7.489258 | 129 | 20 | 1,650 | 0 | null |
no(M2 and SIP pres)
| 0.494751 |
4,796 | 66.086 | 1 |
male
| 0 | 11 | 548 |
Lung Cancer
|
Cancer
| 1 | 3 |
$11-$25k
| 0 | 22,257 | 13,260.1797 | 12,577 | 12.5 |
white
| 18.597656 | 24 | 0.671997 | 0.372986 | 1 | 0 | 0 |
metastatic
| 1 | 1 |
no dnr
| 11 | 117 | 6.299805 | 145 | 8 | 39.5 | 338.0625 | 3 | null | 0.5 | 129 | 7.509766 | 199 | 12 | 2,750 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
4,797 | 36.181 | 0 |
female
| 0 | 12 | 816 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 14 |
under $11k
| 0 | 25,602 | 16,377.4219 | 19,751 | 22 |
white
| 21 | 17 | 0.907959 | 0.875 | 1 | 0 | 0 |
no
| 0.9 | 0.9 |
no dnr
| 12 | 117 | 20 | 155 | 44 | 39.69531 | 117 | 2.399902 | 4.199219 | 0.5 | 144 | 7.329102 | 82 | 5 | 4,045 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
4,798 | 48.99698 | 1 |
male
| 0 | 3 | 97 |
Colon Cancer
|
Cancer
| 3 | 9 |
under $11k
| 0 | 5,688 | 3,466.8477 | 2,897 | 1 |
white
| 15 | 27 | 0.865967 | 0.699951 | 1 | 0 | 0 |
metastatic
| 0.9 | 0.7 |
no dnr
| 3 | 65 | 8.199219 | 170 | 40 | 38.09375 | 136 | null | null | 0.699951 | 132 | 7.329102 | 150 | 7 | 2,570 | null | null |
adl>=4 (>=5 if sur)
| 1.943359 |
4,799 | 67.25299 | 1 |
male
| 1 | 9 | 9 |
COPD
|
COPD/CHF/Cirrhosis
| 1 | 17 |
$25-$50k
| 0 | 37,006 | 21,821.0156 | 23,331 | 29 |
white
| 31.898438 | 46 | 0.595947 | 0.405945 | 6 | 0 | 0 |
no
| 0.5 | 0.2 |
dnr before sadm
| -5 | 42 | 0.299988 | 165 | 26 | 35.89844 | 284 | null | 25.097656 | 4.599609 | 141 | 7.369141 | 81 | 132 | 2,420 | null | 6 |
<2 mo. follow-up
| 6 |
4,800 | 51.978 | 1 |
female
| 0 | 6 | 347 |
Lung Cancer
|
Cancer
| 1 | 11 |
$11-$25k
| 0 | 12,753 | 6,469.1133 | 3,181 | 11 |
white
| 15.699219 | 13 | 0.760986 | 0.507935 | 1 | 0 | 0 |
metastatic
| 1 | 0.8 |
no dnr
| 6 | 123 | 22.898438 | 117 | 28 | 36.39844 | 164.28125 | null | 0.799927 | 0.699951 | 138 | 7.399414 | 211 | 12 | 1,400 | 0 | null |
no(M2 and SIP pres)
| 0.494751 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.